S
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13D/A61.8 KBSIRNA THERAPEUTICS INCJan 3, 2:14 PM ET·0000950133-07-000013
- 8-K74.3 KBSIRNA THERAPEUTICS INCDec 22, 1:22 PM ET·0000950134-06-023620
- 8-K14.3 KBSIRNA THERAPEUTICS INCJun 20, 4:46 PM ET·0000950149-06-000354
- 45.9 KBSIRNA THERAPEUTICS INCJun 20, 2:14 PM ET·0001293941-06-000015
- 4/A6.6 KBSIRNA THERAPEUTICS INCJun 19, 5:16 PM ET·0001239242-06-000002
- 8-K42.0 KBSIRNA THERAPEUTICS INCMay 2, 3:03 PM ET·0000950134-06-008493
- 47.9 KBSIRNA THERAPEUTICS INCAug 31, 6:32 PM ET·0001144204-05-027745
- 8-K23.5 KBSIRNA THERAPEUTICS INCAug 30, 5:13 PM ET·0001144204-05-027572
- 8-K48.4 KBSIRNA THERAPEUTICS INCAug 9, 4:33 PM ET·0001144204-05-024300
- SC 13D/A417.1 KBSIRNA THERAPEUTICS INCJul 20, 6:05 AM ET·0001144204-05-022023
Insiders
10- CHOWRIRA BHARAT MVP Legal & Chief Patent Couns
- COOK JEREMY CURNOCKDirector
- CREDIT SUISSE AG/10% Owner
- FAMBROUGH DOUGLASDirector
- FRENCH J MICHAELSr. VP, Corporate Development
- GREER R SCOTTDirector
- GUERCIOLINI ROBERTOChief Med Off & Sr. VP of Dev.
- LANGER DENNISDirector
- MRNA FUND II LP10% Owner
- NIEDEL JAMESDirector
Tickers
No tickers on record
Addresses
business
185 BERRY STREET SUITE 6504
SAN FRANCISCO, CA, 94107
mailing
185 BERRY STREET SUITE 6504
SAN FRANCISCO, CA, 94107
Former Names
- RIBOZYME PHARMACEUTICALS INC2003-03-28